Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients: Comparison Between Stress Echocardiography and Stress Scintigraphy in the Detection of Silent Myocardial Ischemia

This study is currently recruiting participants.

Verified by Société Française de Cardiologie, January 2004

First Received: September 13, 2005 Last Updated: January 18, 2006 History of Changes

Sponsor:	Société Française de Cardiologie
Information provided by:	Société Française de Cardiologie
ClinicalTrials.gov Identifier:	NCT00202670

Purpose

The aim of this study is to determine in high risk diabetics if the positive predictive value of stress echocardiography is superior to the positive predictive value of stress scintigraphy in the diagnosis of coronary stenosis > 50%

Condition	Phase
Diabetes Mellitus	Phase IV

Study Type:	Observational
Study Design:	Screening, Longitudinal, Random Sample, Prospective Study
Official Title:	Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients: Comparison Between Stress Echocardiography and Stress Scintigraphy in the Detection of Silent Myocardial Ischemia

Resource links provided by NLM:

MedlinePlus related topics: Coronary Artery Disease Diabetes Nuclear Scans

U.S. FDA Resources

Further study details as provided by Société Française de Cardiologie:

Estimated Enrollment:	220
Study Start Date:	January 2004
Estimated Study Completion Date:	January 2008

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

type 2 diabetic patients in women> 60 yo or men > 55 yo, with high risk of coronary artery disease (EF < 40%, ECG abnormalities, renal failure , 2 others risk factors of atherosclerosis)

Exclusion Criteria:

previous documented CAD acute coronary syndrome

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00202670

Contacts

Contact: Sophie Jacqueminet, MD

33 1 42 17 80 61

sophie.jacqueminet@psl.ap-hop-paris.fr

Locations

France
Pitie Salpetriere	Recruiting
Paris, France, 75013
Contact: Sophie Jacqueminet 33 1 42 17 80 61 sophie.jacqueminet@psl.ap-hop-paris.fr
Sub-Investigator: Sophie Jacqueminet, MD

Sponsors and Collaborators

Société Française de Cardiologie

Investigators

Principal Investigator:

Claude Le Feuvre, MD

AP-HP

More Information

No publications provided

Study ID Numbers:	2003-04
Study First Received:	September 13, 2005
Last Updated:	January 18, 2006
ClinicalTrials.gov Identifier:	NCT00202670 History of Changes
Health Authority:	France: AP HP

Keywords provided by Société Française de Cardiologie:

coronary artery disease
stress myocardial scintigraphy
stress echocardiography

Additional relevant MeSH terms:

Arterial Occlusive Diseases
Heart Diseases
Metabolic Diseases
Myocardial Ischemia
Diabetes Mellitus
Vascular Diseases
Stress

Endocrine System Diseases
Arteriosclerosis
Coronary Disease
Pathologic Processes
Cardiovascular Diseases
Glucose Metabolism Disorders
Coronary Artery Disease

ClinicalTrials.gov processed this record on November 09, 2009